retatrutide clinical trial results Dr. Tara Narula breaks down new data on the weight-loss drug and the latest results. | Good Morning America Retatrutide clinical trial done! Now

While unenthusiastic about obesity, Srenson nonetheless agreed to support clinical trials to assess liraglutide's effect on obesity

" More research is needed into why and how these taste change vary across individuals as GLP-1s become an increasingly mainstream option for weight loss, Doty and other experts say especially as use among Americans has more than doubled in the past year

Both companies have heavily invested in improving their supply chains and manufacturing capacity over the past few years

Do not use GLP-1s if you are pregnant or breastfeeding, or planning to become pregnant or breastfeed

The regulatory landscape and what it means for dosing The availability and dosage charts of these compounds are tied to their regulatory status, and that status affects everything from access to quality to clinical support

"GLP-3" is an informal term used in community discussions to refer to third-generation GLP-class peptides specifically retatrutide and other triple agonists